Diabetologia

Papers
(The H4-Index of Diabetologia is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)412
Hypoxia and hypoxia-inducible factors in diabetes and its complications197
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses170
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)164
New closed-loop insulin systems154
Interpreting global trends in type 2 diabetes complications and mortality153
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies143
Sex differences in type 2 diabetes126
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis123
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study118
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial114
Incidence of newly diagnosed diabetes after Covid-19113
Defining the underlying defect in insulin action in type 2 diabetes107
Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults106
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission90
The consequences of hypoglycaemia87
Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants85
Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney disease85
Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature81
Current and future therapies for type 1 diabetes76
Environmental risk factors of type 2 diabetes—an exposome approach72
A global perspective on the issue of access to insulin70
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment68
The promise of stem cell-derived islet replacement therapy66
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis64
Pancreatic beta cell autophagy is impaired in type 1 diabetes63
Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis63
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes61
The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials58
Diabetes and the COVID-19 pandemic57
Evidence-based European recommendations for the dietary management of diabetes57
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues55
The effect of morning vs evening exercise training on glycaemic control and serum metabolites in overweight/obese men: a randomised trial55
Cardiovascular outcomes in type 1 and type 2 diabetes54
M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice53
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial53
Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings51
The expanding incretin universe: from basic biology to clinical translation51
Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study)48
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 data48
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial48
Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction48
Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes47
Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice47
Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial47
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study47
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study46
HDL and type 2 diabetes: the chicken or the egg?46
0.078583955764771